Skip to Content

Ben Verwaayen’s Keynote

Alcatel-Lucent’s CEO on innovation and misreading Facebook.
September 23, 2009

Ben Verwaayen, CEO of Alcatel-Lucent, gave the keynote this morning at EmTech09. Here are reports from around the Web on what he had to say.

The Industry Standard:

EmTech: Innovation’s Achilles heel, and misreading the Facebook generation
Furthering innovation is a given, but you also have to identify technologies that will resonate with consumers – not to mention building sustainable business models around them. This is the world that Alcatel-Lucent CEO Ben Verwaayen inhabits…

Gigaom:

Alcatel-Lucent CEO’s 3 Ingredients for a Successful Product
He spoke of tech innovations and – perhaps most importantly – the need to turn them into sustainable, profitable businesses. During the question-and-answer session, which always manages to be more interesting than the actual talk, Verwaayen shared his three requirements for a product to be successful…

Reuters:

Alcatel says not in talks with big rivals
The chief executive of telecommunications equipment giant Alcatel-Lucent (ALUA.PA) said his company is not in merger talks with any of its rivals, dismissing speculation a deal might be in the works. “There is nothing going on,” Alcatel-Lucent CEO Ben Verwaayen told Reuters in an interview…

Keep Reading

Most Popular

open sourcing language models concept
open sourcing language models concept

Meta has built a massive new language AI—and it’s giving it away for free

Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3

transplant surgery
transplant surgery

The gene-edited pig heart given to a dying patient was infected with a pig virus

The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.

Muhammad bin Salman funds anti-aging research
Muhammad bin Salman funds anti-aging research

Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging

The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.

Yann LeCun
Yann LeCun

Yann LeCun has a bold new vision for the future of AI

One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.